JPRN-UMIN000000760已完成1 期
Phase I clinical trial of pan-HLA type personalized peptide vaccine for advanced pediatric malignant glioma patients - Pan-HLA type personalized peptide vaccine trial for pediatric malignant glioma patients
Department of Immunology, Kurume University School of Medicine0 个研究点目标入组 10 人开始时间: 2007年7月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients must be excluded: 1) Patients with cerebral or cerebellar grade I or II glioma. 2) Patients with severe symptoms (circulatory disease, respiratory disease, kidney disease, immunodeficiency, disturbance of coagulation etc). 3) Patients with the past history of severe allergic reactions. 4) Patients with active infectious disease 5) Pregnant, nursing, or who wants pregnancy. Patients with no acceptance of use effective contraception during and for at least 70 days after study participation. 6) Patients who are judged inappropriate for the clinical trial by doctors.
研究者
相似试验
已完成
1 期
Phase I clinical trial of pan-HLA type personalized peptide vaccine for advanced cancer patientsAdvanced cancer patients who are refractory to standard therapies for cancerJPRN-UMIN000000619Department of Immunology, Kurume University School of Medicine40
已完成
1 期
A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioningChronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphomaJPRN-C000000253Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare25
已完成
1 期
Phase I clinical trial of HLA-A*2402 restricted epitope peptide cocktail therapy with S-1 for patients with unresectable advanced metastatic pancreatic cancer.pancreatic cancerJPRN-UMIN000009881Sapporo Medical University9
已完成
1 期
Phase I/II clinical trial of HLA-A24 restricted epitope peptide cocktail therapy with UFT+LV for patients with advanced metastatic colorectal cancer.Advanced metastatic colorectal cancersJPRN-UMIN000007801Kinki University School of Medicine30
招募中
2 期
Clinical trial for HLA-haploidentical transplantation using alpha-beta T cell and B cell depletioJPRN-jRCTs032230287Iguchi Akihiro3